Galactomannan (Aspergillus Antigen), Bronchoalveolar Lavage Test
Galactomannan (Aspergillus Antigen), Bronchoalveolar Lavage Test
The galactomannan (Aspergillus antigen), bronchoalveolar lavage test is used to detect the presence of galactomannan in the bronchoalveolar lavage (BAL) fluid specimens. Galactomannan is a sugar molecule found in the cell walls of Aspergillus, a common type of fungus. This test is crucial in identifying Aspergillus infection within the body.
Aspergillus is known to cause a range of diseases collectively referred to as aspergillosis, which can manifest in various forms including simple allergic reactions, growth in the lungs (aspergilloma), or severe systemic infections (invasive aspergillosis).
Thus, getting this test is recommended for individuals with weakened immune systems, such as those undergoing chemotherapy or organ transplantation, who are particularly vulnerable to invasive aspergillosis.
Symptoms of invasive aspergillosis
Coughing
Coughing blood
Shortness of breath
Chest pain or tightness
Fever
Why is the Galactomannan (Aspergillus Antigen), Bronchoalveolar Lavage test performed?
This test is typically recommended
To aid in the diagnosis of invasive aspergillosis in the bronchoalveolar lavage fluid specimens
To assess response to therapy
Preparation for the test
The galactomannan (Aspergillus antigen), bronchoalveolar lavage test does not necessitate any specific preparation.
Interpretation of test results
The results of the galactomannan (Aspergillus antigen), bronchoalveolar lavage tests are available as either positive or negative.
Reference value: <0.5 Index
Positive test results
A positive test result in BAL fluid can help confirm a diagnosis of invasive aspergillosis. It is important to interpret positive results in combination with other diagnostic methods, including microbiologic culture, histological analysis of biopsy samples, and radiographic findings.
Negative test results
A negative test result in BAL fluid does not definitively exclude the possibility of an invasive aspergillosis (IA) diagnosis. It is important to monitor patients who are at risk of IA by conducting Aspergillus antigen level serum tests twice a week until it is determined to be clinically unnecessary.
FAQs
What is bronchoalveolar lavage?
Bronchoalveolar lavage (BAL) is a procedure commonly performed during a bronchoscopy. It is used to obtain a sample from the lungs for testing. By introducing a saline solution through the bronchoscope, the airways are washed and the fluid sample is collected.
What is the turnaround time (TAT) for the results of the galactomannan (Aspergillus antigen), bronchoalveolar lavage test?
The turnaround time of the test results is one day upon receipt at the reference laboratory. This duration may vary depending on the particular diagnostic clinic.
Does the galactomannan (Aspergillus antigen), bronchoalveolar lavage test pose any risks?
Bronchoscopy or BAL procedures pose minimal risk, with potential side effects such as temporary throat discomfort. Although rare, there is still a possibility for serious complications such as airway bleeding, infection, or lung collapse to occur.
Can Aspergillus infections be prevented?
Completely avoiding Aspergillus is a difficult due to its common occurrence in the environment. However, individuals who are at risk should take precautions by staying away from areas with high levels of dust and mold. Additionally, it is essential for them to ensure their living spaces are clean and properly ventilated.
What are the limitations of the galactomannan (Aspergillus antigen), bronchoalveolar lavage test?
The test's specificity for Aspergillus species does not rule out the potential involvement of other fungal pathogens like Fusarium, Alternaria, and Mucorales, which present similar clinical symptoms. Additionally, the concurrent administration of antifungal treatment to certain patients with invasive aspergillosis could lead to a decrease in the test's sensitivity.
Related tests
Tests At Lupin Diagnostics